Aussie researchers close to schizophrenia breakthrough

AUSTRALIAN researchers are getting closer to finding a solution to helping sufferers of schizophrenia deal with the chemical balance.

Researchers at Monash University, together with United States researchers, may have found a drug which "dials down" the effects of the disease.

The drug, called SB269652, could potentially modulate the effects of dopamine - a key chemical in the brain - on the brains' dopamine receptors.

While only in its early stages, it could help reduce the effect of dopamine on the brain, without the side effects of other drugs which turn it off completely.